Bioalpha Holdings Bhd
KLSE:BIOHLDG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bioalpha Holdings Bhd
KLSE:BIOHLDG
|
MY |
|
Grupo Sports World SAB de CV
BMV:SPORTS
|
MX |
|
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
IN |
|
F
|
Fidelity National Information Services Inc
SWB:ZGY
|
US |
|
Ujaas Energy Ltd
NSE:UJAAS
|
IN |
Balance Sheet
Balance Sheet Decomposition
Bioalpha Holdings Bhd
Bioalpha Holdings Bhd
Balance Sheet
Bioalpha Holdings Bhd
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
2
|
9
|
6
|
2
|
7
|
5
|
3
|
12
|
24
|
17
|
12
|
7
|
4
|
|
| Cash |
1
|
1
|
2
|
9
|
6
|
2
|
7
|
5
|
3
|
12
|
24
|
17
|
12
|
7
|
4
|
|
| Short-Term Investments |
0
|
1
|
9
|
1
|
8
|
4
|
19
|
19
|
10
|
16
|
12
|
32
|
22
|
30
|
16
|
|
| Total Receivables |
11
|
14
|
17
|
14
|
30
|
46
|
47
|
49
|
49
|
28
|
32
|
18
|
13
|
3
|
3
|
|
| Accounts Receivables |
11
|
13
|
13
|
13
|
19
|
29
|
32
|
40
|
45
|
22
|
24
|
9
|
6
|
1
|
2
|
|
| Other Receivables |
0
|
2
|
4
|
2
|
11
|
17
|
15
|
9
|
5
|
5
|
8
|
9
|
7
|
2
|
2
|
|
| Inventory |
1
|
1
|
3
|
4
|
5
|
8
|
8
|
10
|
11
|
8
|
11
|
9
|
7
|
4
|
3
|
|
| Other Current Assets |
4
|
1
|
6
|
5
|
0
|
0
|
0
|
9
|
9
|
9
|
11
|
8
|
0
|
5
|
0
|
|
| Total Current Assets |
16
|
18
|
37
|
34
|
49
|
61
|
81
|
90
|
81
|
72
|
90
|
84
|
53
|
48
|
26
|
|
| PP&E Net |
8
|
15
|
17
|
24
|
27
|
29
|
37
|
48
|
62
|
62
|
72
|
59
|
54
|
33
|
24
|
|
| PP&E Gross |
8
|
15
|
17
|
24
|
0
|
0
|
0
|
48
|
62
|
62
|
72
|
59
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
1
|
3
|
5
|
0
|
0
|
0
|
0
|
25
|
31
|
42
|
47
|
49
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
1
|
6
|
8
|
13
|
19
|
31
|
36
|
45
|
48
|
51
|
52
|
47
|
38
|
28
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
5
|
5
|
6
|
6
|
5
|
5
|
5
|
5
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
5
|
5
|
6
|
6
|
5
|
5
|
5
|
5
|
0
|
0
|
|
| Total Assets |
25
N/A
|
35
+42%
|
60
+72%
|
66
+11%
|
89
+34%
|
114
+28%
|
154
+35%
|
179
+16%
|
194
+8%
|
187
-3%
|
217
+16%
|
201
-8%
|
163
-19%
|
119
-27%
|
79
-33%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
1
|
2
|
1
|
0
|
0
|
4
|
5
|
5
|
4
|
3
|
5
|
5
|
4
|
2
|
1
|
|
| Accrued Liabilities |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
2
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
4
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
2
|
2
|
4
|
2
|
2
|
1
|
1
|
|
| Other Current Liabilities |
3
|
3
|
4
|
5
|
5
|
7
|
6
|
3
|
3
|
2
|
3
|
7
|
12
|
10
|
6
|
|
| Total Current Liabilities |
5
|
6
|
7
|
8
|
6
|
11
|
12
|
10
|
11
|
10
|
15
|
18
|
22
|
13
|
7
|
|
| Long-Term Debt |
2
|
3
|
3
|
3
|
1
|
3
|
3
|
5
|
9
|
8
|
9
|
7
|
6
|
4
|
4
|
|
| Deferred Income Tax |
0
|
0
|
2
|
2
|
3
|
2
|
4
|
6
|
8
|
9
|
7
|
7
|
6
|
4
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
2
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
7
N/A
|
10
+48%
|
11
+19%
|
12
+5%
|
10
-19%
|
16
+64%
|
18
+16%
|
21
+16%
|
28
+33%
|
26
-7%
|
31
+17%
|
33
+7%
|
36
+9%
|
21
-42%
|
10
-53%
|
|
| Equity | ||||||||||||||||
| Common Stock |
13
|
13
|
18
|
18
|
23
|
33
|
87
|
100
|
100
|
136
|
162
|
189
|
189
|
189
|
79
|
|
| Retained Earnings |
5
|
12
|
19
|
25
|
31
|
40
|
48
|
58
|
66
|
25
|
24
|
24
|
62
|
91
|
10
|
|
| Additional Paid In Capital |
0
|
0
|
12
|
12
|
24
|
25
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Total Equity |
18
N/A
|
25
+39%
|
49
+93%
|
54
+12%
|
79
+45%
|
98
+24%
|
135
+38%
|
158
+16%
|
166
+5%
|
161
-3%
|
187
+16%
|
168
-10%
|
127
-24%
|
98
-23%
|
69
-29%
|
|
| Total Liabilities & Equity |
25
N/A
|
35
+42%
|
60
+72%
|
66
+11%
|
89
+34%
|
114
+28%
|
154
+35%
|
179
+16%
|
194
+8%
|
187
-3%
|
217
+16%
|
201
-8%
|
163
-19%
|
119
-27%
|
79
-33%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
343
|
343
|
490
|
490
|
625
|
669
|
812
|
863
|
862
|
1 114
|
1 197
|
1 378
|
1 406
|
1 406
|
1 406
|
|